An FDA advisory committee will meet today to discuss the safety and efficacy of Pfizer’s booster vaccine. The move comes as debate heats up over who should receive a third dose to protect against the coronavirus, and when. Ed O’Keefe reports. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.